跳至主要内容
临床试验/NCT03594188
NCT03594188已完成不适用

Effects of Serum From Hepatocellular Carcinoma Surgery Patients Under Different Anesthetic Methods on Hepatic Cancer Cell Malignancy in Vitro

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2018年7月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
1
主要终点
cell proliferation

研究概览

简要总结

Numerous studies found that anesthetic methods can influence the recurrence of tumor and the overall survival of patients after primary cancer surgery. Radiofrequency (RF) ablation is now widely used in clinic for treatment of hepatocellular carcinoma (HCC). Currently, diverse anesthetic methods, including general anesthesia (GA), epidural anesthesia and local anesthesia (LA), are used for RF ablation surgery. Using serum from HCC surgery patients randomized to receive either GA or LA during surgery, we investigated the effects of anesthetic methods on proliferation, migration and metastasis in HepG2 hepatic cancer cells in vitro.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with a single primary liver tumor of 3cm or smaller, who are scheduled for RF ablation surgery

排除标准

  • less than 18 or more than 65 years old;
  • ASA Physical Status 4 or greater;
  • previous surgery in liver (including radiofrequency ablation);
  • severe systemic disease (heart, lung, kidney, or immune system);
  • INR>1.5 or platelet count <45,000 cells/mm3;
  • a history of addiction to opioids;
  • with known extension beyond the liver;
  • Child-Pugh Class C.

结局指标

主要结局

cell proliferation

时间窗: 1 hour post-surgery

HepG2 cells will be cultured with serum from patients undergoing RF ablation under GA or LA for 24h and cell proliferation will be measured

次要结局

  • cell metastasis(1 hour post-surgery)
  • cell migration(1 hour post-surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jie Tian

Professor

RenJi Hospital

研究点 (1)

Loading locations...

相似试验